MaxCyte MXCT EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from MaxCyte’s reported figures.
Based on trailing twelve months.
The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about MaxCyte's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MaxCyte's EBITDA margin?
- MaxCyte (MXCT) reported EBITDA margin of -128.5% in Q1 2026.
- How has MaxCyte's EBITDA margin changed year-over-year?
- MaxCyte's EBITDA margin decreased by 3.2% year-over-year, from -124.5% to -128.5%.
- What is the long-term trend for MaxCyte's EBITDA margin?
- Over 5 years (2020 to 2025), MaxCyte's EBITDA margin has grown at a 30.4% compound annual growth rate (CAGR), from -38.2% to -144%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.